Journal ArticleDOI
Gaps in cardiovascular disease risk management in Australian general practice.
Reads0
Chats0
TLDR
To evaluate the management of cardiovascular disease risk in Australian general practice, a large number of patients with a history of CVD are referred to general practice for routine check-ups.Abstract:
Objective: To evaluate the management of cardiovascular disease (CVD) risk in Australian general practice.read more
Citations
More filters
Journal ArticleDOI
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton,Robert M. Carey,Wilbert S. Aronow,Donald E. Casey,Karen J. Collins,Cheryl Dennison Himmelfarb,Sondra M. DePalma,Samuel S. Gidding,Kenneth Jamerson,Daniel W. Jones,Eric J. MacLaughlin,Paul Muntner,Bruce Ovbiagele,Sidney C. Smith,Crystal C. Spencer,Randall S. Stafford,Sandra J. Taler,Randal J. Thomas,Kim A. Williams,Jeff D. Williamson,Jackson T. Wright +20 more
TL;DR: Since 1980, the American College of Cardiology and American Heart Association have translated scientific evidence into clinical practice guidelines (guidelines) with recommendations to improve cardiovascular health.
Journal ArticleDOI
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton,Robert M. Carey,Wilbert S. Aronow,Donald E. Casey,Karen J. Collins,Cheryl Dennison Himmelfarb,Sondra M. DePalma,Samuel S. Gidding,Kenneth Jamerson,Daniel W. Jones,Eric J. MacLaughlin,Paul Muntner,Bruce Ovbiagele,Sidney C. Smith,Crystal C. Spencer,Randall S. Stafford,Sandra J. Taler,Randal J. Thomas,Kim A. Williams,Jeff D. Williamson,Jackson T. Wright +20 more
TL;DR: The next generation of scientists and decision-makers will have a greater understanding of what constitutes a credible threat to public health and how to protect them from that threat.
Journal ArticleDOI
Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD: The UMPIRE Randomized Clinical Trial
Simon Thom,Neil Poulter,Jane Field,Anushka Patel,Dorairaj Prabhakaran,Alice Stanton,Diederick E. Grobbee,Michiel L. Bots,K. Srinath Reddy,Raghu Cidambi,Severine Bompoint,Laurent Billot,Anthony Rodgers +12 more
TL;DR: There was consistency of effects across predefined subgroups, and evidence existed of larger benefits in patients with lower adherence at baseline, which resulted in significantly improved medication adherence at the end of the study.
Aboriginal and Torres Strait Islander health performance framework
TL;DR: This report gives the latest information on how Aboriginal and Torres Strait Islander people in the Northern Territory are faring according to a range of measures of health status and outcomes, determinants of health and health system performance.
Journal ArticleDOI
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.
Anthony Rodgers,Anushka Patel,Otavio Berwanger,M. L. Bots,Richard H. Grimm,D. E. Grobbee,Rod Jackson,Bruce Neal,James D. Neaton,Neil R Poulter,Natasha Rafter,P. K. Raju,Srinath Reddy,Simon Thom,S. Vander Hoorn,Ruth Webster +15 more
TL;DR: This polypill achieved sizeable reductions in SBP and LDL-cholesterol but caused side effects in about 1 in 6 people, the halving in predicted cardiovascular risk is moderately lower than previous estimates and the side effect rate is moderately higher.
References
More filters
Journal ArticleDOI
Cardiovascular disease risk profiles
TL;DR: The equations demonstrated the potential importance of controlling multiple risk factors (blood pressure, total cholesterol, high-density lipoprotein cholesterol, smoking, glucose intolerance, and left ventricular hypertrophy) as opposed to focusing on one single risk factor.
Journal ArticleDOI
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith,Jerilyn K. Allen,Steven N. Blair,Robert O. Bonow,Lawrence M. Brass,Gregg C. Fonarow,Scott M. Grundy,Loren F. Hiratzka,Daniel W. Jones,Harlan M. Krumholz,Lori Mosca,Richard C. Pasternak,Thomas A. Pearson,Marc A. Pfeffer,Kathryn A. Taubert +14 more
TL;DR: The development of the present statement involved a process of partial adaptation of other guideline statements and reports and supplemental literature searches, which confirmed that aggressive comprehensive risk factor management improves survival, reduces recurrent events and the need for interventional procedures, and improves quality of life for patients with established coronary disease.
Journal ArticleDOI
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.
TL;DR: The rationale for targeting blood pressure and blood cholesterol lowering drug treatments to patients at high absolute cardiovascular risk, irrespective of their blood pressure or blood cholesterol levels is outlined.
Journal ArticleDOI
Updated New Zealand cardiovascular disease risk-benefit prediction guide
TL;DR: This guide provides a simple quantitative method for assessing a person's risk of cardiovascular disease and the likely benefits of lowering blood pressure or blood cholesterol with drugs and combines and update previous New Zealand cardiovascular disease risk assessment charts.
Journal ArticleDOI
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
Andrew Tonkin,Philip J. Barter,James D. Best,Andrew Boyden,John Furler,Ken Hossack,David R. Sullivan,Peter L. Thompson,Margarite J. Vale,Catherine Cooper,Malia Robinson,Eleanor Clune,New Zealand +12 more
Related Papers (5)
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
Salim Yusuf,Shofiqul Islam,Clara K Chow,Sumathy Rangarajan,Gilles R. Dagenais,Rafael Diaz,Rajeev Gupta,Roya Kelishadi,Romaina Iqbal,Alvaro Avezum,Annamarie Kruger,Raman Kutty,Fernando Lanas,Liu Lisheng,Li Wei,Patricio Lopez-Jaramillo,Aytekin Oguz,Omar Rahman,H Swidan,Khalid Yusoff,Witold Zatonski,Annika Rosengren,Koon K. Teo +22 more